ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
Targeted Treatment of Chronic Lymphocytic Leukemia: Clinical Utility of Acalabrutinib
OncoTargets and Therapy
◽
10.2147/ott.s303060
◽
2021
◽
Vol Volume 14
◽
pp. 5507-5519
Author(s):
Candida Vitale
◽
Jamie Lynn Gibbons
◽
Alessandra Ferrajoli
Keyword(s):
Chronic Lymphocytic Leukemia
◽
Clinical Utility
◽
Lymphocytic Leukemia
◽
Targeted Treatment
Download Full-text
Related Documents
Cited By
References
Clinical Utility of Monoclonal Antibodies in the Phenotyping of Acute and Chronic Lymphocytic Leukemia
Protides of the Biological Fluids
◽
10.1016/b978-0-08-029815-3.50095-7
◽
1983
◽
pp. 417-422
Author(s):
R.E. SOBOL
◽
R.O. DILLMAN
◽
J.C. BEAUREGARD
◽
A.L. YU
◽
J.W. LEA
◽
...
Keyword(s):
Monoclonal Antibodies
◽
Chronic Lymphocytic Leukemia
◽
Clinical Utility
◽
Lymphocytic Leukemia
Download Full-text
A novel, mitochondrial, internal tRNA-derived RNA fragment possesses clinical utility as a molecular prognostic biomarker in chronic lymphocytic leukemia
Clinical Biochemistry
◽
10.1016/j.clinbiochem.2020.07.005
◽
2020
◽
Vol 85
◽
pp. 20-26
Author(s):
Paraskevi Karousi
◽
Panagiotis G. Adamopoulos
◽
Sotirios G. Papageorgiou
◽
Vasiliki Pappa
◽
Andreas Scorilas
◽
...
Keyword(s):
Chronic Lymphocytic Leukemia
◽
Clinical Utility
◽
Prognostic Biomarker
◽
Lymphocytic Leukemia
Download Full-text
Clinical Utility of the Collect Scale To Assess Comorbidities In Patients With Chronic Lymphocytic Leukemia
Value in Health
◽
10.1016/j.jval.2014.08.1632
◽
2014
◽
Vol 17
(7)
◽
pp. A522
Author(s):
La Serna J. De
◽
F. Carbonell
◽
P. Giraldo
◽
A. Lopez
◽
I. González
◽
...
Keyword(s):
Chronic Lymphocytic Leukemia
◽
Clinical Utility
◽
Lymphocytic Leukemia
Download Full-text
Chemoimmunotherapy Versus Targeted Treatment in Chronic Lymphocytic Leukemia: When, How Long, How Much, and in Which Combination?
American Society of Clinical Oncology Educational Book
◽
10.14694/edbk_159018
◽
2016
◽
Vol 36
◽
pp. e387-e398
◽
Cited By ~ 15
Author(s):
Jennifer R. Brown
◽
Michael J. Hallek
◽
John M. Pagel
Keyword(s):
Chronic Lymphocytic Leukemia
◽
Lymphocytic Leukemia
◽
Targeted Treatment
Download Full-text
Clinical utility of assessing ZAP-70 and CD38 in chronic lymphocytic leukemia
Cytometry Part B Clinical Cytometry
◽
10.1002/cyto.b.20129
◽
2006
◽
Vol 70B
(4)
◽
pp. 209-213
◽
Cited By ~ 20
Author(s):
Laura Z. Rassenti
◽
Thomas J. Kipps
Keyword(s):
Chronic Lymphocytic Leukemia
◽
Clinical Utility
◽
Lymphocytic Leukemia
Download Full-text
Targeted treatment for chronic lymphocytic leukemia
OncoTargets and Therapy
◽
10.2147/ott.s7173
◽
2011
◽
pp. 169
◽
Cited By ~ 1
Author(s):
Asher Chanan-Khan
Keyword(s):
Chronic Lymphocytic Leukemia
◽
Lymphocytic Leukemia
◽
Targeted Treatment
Download Full-text
Clinical utility and patient considerations in the use of ofatumumab in chronic lymphocytic leukemia
Biologics Targets and Therapy
◽
10.2147/btt.s60503
◽
2015
◽
pp. 75
Author(s):
Marco Montillo
◽
Anna Maria Frustaci
◽
Alessandra Tedeschi
◽
Paola Picardi
◽
Roberto Cairoli
Keyword(s):
Chronic Lymphocytic Leukemia
◽
Clinical Utility
◽
Lymphocytic Leukemia
Download Full-text
Targeted treatment for chronic lymphocytic leukemia: clinical potential of obinutuzumab
Pharmacogenomics and Personalized Medicine
◽
10.2147/pgpm.s55501
◽
2014
◽
pp. 1
◽
Cited By ~ 1
Author(s):
Lukas Smolej
Keyword(s):
Chronic Lymphocytic Leukemia
◽
Lymphocytic Leukemia
◽
Targeted Treatment
◽
Clinical Potential
Download Full-text
The clinical utility of polygenic risk scores for chronic lymphocytic leukemia
Leukemia
◽
10.1038/s41375-021-01429-5
◽
2021
◽
Author(s):
Amit Sud
◽
Philip J. Law
◽
Richard S. Houlston
Keyword(s):
Chronic Lymphocytic Leukemia
◽
Clinical Utility
◽
Lymphocytic Leukemia
◽
Risk Scores
◽
Polygenic Risk
Download Full-text
CLL2-BXX Phase II trials: sequential, targeted treatment for eradication of minimal residual disease in chronic lymphocytic leukemia
Future Oncology
◽
10.2217/fon-2017-0442
◽
2018
◽
Vol 14
(6)
◽
pp. 499-513
◽
Cited By ~ 18
Author(s):
Paula Cramer
◽
Julia von Tresckow
◽
Jasmin Bahlo
◽
Anja Engelke
◽
Petra Langerbeins
◽
...
Keyword(s):
Chronic Lymphocytic Leukemia
◽
Minimal Residual Disease
◽
Phase Ii
◽
Residual Disease
◽
Lymphocytic Leukemia
◽
Targeted Treatment
◽
Phase Ii Trials
◽
Minimal Residual
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close